Illumina Inc (NASDAQ:ILMN)

295.00
Delayed Data
As of Nov 11
 +1.61 / +0.55%
Today’s Change
263.30
Today|||52-Week Range
380.76
-1.64%
Year-to-Date
Illumina's Next Big Move: Distributed Diagnostics
Nov 01 / MotleyFool.com - Paid Partner Content
Why Investors Weren't Excited About Illumina's Q3 Earnings Beat
Oct 25 / MotleyFool.com - Paid Partner Content
2 Stocks That Flopped This Week
Oct 27 / MotleyFool.com - Paid Partner Content
Illumina Inc (ILMN) Q3 2019 Earnings Call Transcript
Oct 25 / MotleyFool.com - Paid Partner Content
5 Top Healthcare ETFs
Oct 26 / MotleyFool.com - Paid Partner Content
Why Pacific Biosciences of California Stock Is Sinking Today
Oct 24 / MotleyFool.com - Paid Partner Content
Better Buy: Illumina vs. Thermo Fisher Scientific
Oct 26 / MotleyFool.com - Paid Partner Content
Has Your Portfolio Moved Beyond Genomics Yet?
Oct 23 / MotleyFool.com - Paid Partner Content
Why Illumina Stock Is Sinking Today
Oct 25 / MotleyFool.com - Paid Partner Content
Why Did the Market Whack This IPO?
Oct 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close293.39
Today’s open293.02
Day’s range290.82 - 295.62
Volume743,530
Average volume (3 months)1,169,537
Market cap$43.1B
Data as of 4:00pm ET, 11/11/2019

Growth & Valuation

Earnings growth (last year)+13.15%
Earnings growth (this year)+12.74%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+21.11%
P/E ratio45.1
Price/Sales13.33
Price/Book11.47

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+0.89+0.30%
BMRNBiomarin Pharmaceuti...-0.57-0.75%
EXASExact Sciences Corp-3.13-3.74%
NBIXNeurocrine Bioscienc...+0.08+0.07%
Data as of 4:00pm ET, 11/11/2019

Financials

Next reporting dateFebruary 4, 2020
EPS forecast (this quarter)$1.57
Annual revenue (last year)$3.3B
Annual profit (last year)$826.0M
Net profit margin24.78%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts